Percorten V

Percorten V Manufacturers

• Novartis Animal Health Us, Inc.
  

  ×

  Percorten V | Novartis Animal Health Us, Inc.

  

  ---

  In treating canine hypoadrenocorticism, PERCORTEN-V replaces the mineralocorticoid hormones only. Glucocorticoid replacement must be supplied by small daily doses of glucocorticoid hormones (e.g., prednisone or prednisolone) (0.2 - 0.4 mg/kg/day).

  Dosage requirements are variable and must be individualized on the basis of the response of the patient to therapy. Begin treatment with PERCORTEN-V at a dose of 1.0 mg per pound of body weight every 25 days. In some patients the dose may be reduced. Serum sodium and potassium levels should be monitored to assure the animal is properly compensated. Most patients are well controlled with a dose range of 0.75 to 1.0 mg per pound of body weight, given every 21 to 30 days.

  The well-controlled patient will have normal electrolytes at 14 days after administration or may exhibit slight hyponatremia and hyperkalemia. This needs no additional therapy as long as the patient is active and eating normally. Watch closely for depression, lethargy, vomiting or diarrhea which indicate a probable glucocorticoid deficiency.

  At the end of the 25-day dosing interval, the patient should be clinically normal and have normal serum electrolytes. Alternatively, they may have slight hyponatremia and slight hyperkalemia. This constellation of signs indicate that the dosage and dosage interval should not be altered.

  If the dog is not clinically normal or serum electrolytes are abnormal, then the dosage interval should be decreased 2-3 days.

  Occasionally, dogs on PERCORTEN-V therapy may develop polyuria and polydipsia (PU/PD). This usually indicates excess glucocorticoid, but may also indicate a PERCORTEN-V excess. It is prudent to begin by decreasing the glucocorticoid dose first. If the PU/PD persists, then decrease the dose of PERCORTEN-V without changing the interval between doses.

  Please note: Failure to administer glucocorticoids is the most common reason for treatment failure. Signs of glucocorticoid deficiency include depression, lethargy, vomiting and diarrhea. Such signs should be treated with high doses of injectable glucocorticoids (prednisolone or dexamethasone), followed by continued oral therapy 0.2 - 0.4 mg/kg/day. Oral supplementation with salt (NaCl) is not necessary with animals receiving PERCORTEN-V.

  Guide to Maintenance Therapy
  Starting Dose:
        DOCP 1 mg/lb every 25 days
        Prednisone 0.2 - 0.4 mg/kg/day

  Guides for Adjustment:
        Clinical Problem/Solution

        Polyuria/Polydipsia
                    → decrease prednisone dose first,
                    → then decrease DOCP dose,
                    → do not change DOCP interval

        Depression, lethargy, vomiting or diarrhea
                    → increase prednisone dose

        Hyperkalemia, Hyponatremia
                    → decrease DOCP interval 2-3 days

  Before injection, shake the vial thoroughly to mix the microcrystals with the suspension vehicle. PERCORTEN-V suspension is to be injected intramuscularly. Care should be used to prevent inadvertent intravenous injection, which may cause acute collapse and shock. Such animals should receive immediate therapy for shock with intravenous fluids and glucocorticoids.

  Once vial is broached, product should be used within 4 months.

  Close
  No Recall

  More Info